Process alone doesn’t drive change—people do. The most meticulously planned strategies will fail if employees aren’t engaged, ...

With long development timelines and high burn rates, biotech companies must navigate capital markets with precision.

PHILADELPHIA--(BUSINESS WIRE)--Rite Aid Corporation (“Rite Aid” or the “Company”) today announced that it is pursuing a strategic and value-maximizing sale process for substantially all of ...

Company in Active Discussions with Multiple Interested Potential Acquirors; Robust Sale Process Supported by ... today announced that it is pursuing a strategic and value-maximizing sale process ...

This seemingly defensive strategy is actually extremely productive for Italy because, meanwhile, the public finances of many other advanced countries are deteriorating dramatically and their debts ...

“Managers that achieve the strategic partner role have more opportunities to grow the relationship,” said Mark Buckley, global head of investment management at Crisil Coalition ...

Artificial intelligence (AI) technology has been praised by many for its ability to improve efficiency, but a lesser- ...

The company reaffirmed its fiscal 2025 guidance, including revenue of $8.7 billion to $9.1 billion, adjusted EBITDA of $950 million to $990 million, and adjusted EPS of $3.71 to $3.95. Operating cash ...

One of the biggest mistakes I see organizations make is that they have a one-for-one approach with limited optionality.

Many organizations still treat supplier risk management as a reactive firefighting exercise, leaving them vulnerable to disruptions that could have been prevented.

Q1 2025 Earnings Call Transcript May 7, 2025 8:30 AM ETCompany ParticipantsAnthony Rozmus - Investor RelationsMatt Stevenson ...